Current Respiratory Medicine Reviews publishes original research papers, frontier reviews, drug clinical trial studies and guest edited issues dedicated to clinical research on all the latest advances on respiratory diseases and its related areas e.g. pharmacology, pathogenesis, clinical care, therapy. The journal is essential reading for all researchers and clinicians in respiratory medicine.
Current Clinical Pharmacology publishes frontier reviews on all the latest advances in clinical pharmacology. The journal aims to publish the highest quality review articles, drug clinical trial studies and guest edited thematic issues in the field. Topics covered include: pharmacokinetics; therapeutic trials; adverse drug reactions; drug interactions; drug metabolism; pharmacoepidemiology; and drug development. The journal is essential reading for all researchers in clinical pharmacology.
This journal aims to review the most important, recently published research in the field of rheumatology. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care and prevention of rheumatologic conditions.
We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas such as the many forms of arthritis, osteoporosis and metabolic bone disease, and systemic lupus erythematosus. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also occasionally provided.
Current Rheumatology Reviews publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on all the latest advances on rheumatology and its related areas e.g. pharmacology, pathogenesis, epidemiology, clinical care and therapy. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field.
Current Science, founded in 1932 is published by the Current Science Association in collaboration with the Indian Academy of Sciences. The journal is also intended as a medium for communication and discussion of important issues that concern science and scientific activity. All articles published in Current Science, especially editorials, opinions and commentaries, letters and book reviews, are deemed to reflect the individual views of the authors and not the official points of view, either of the Current Science Association or of the Indian Academy of Sciences.
The aim of this journal is to help the reader, by providing in a systematic manner, the views of experts on the current advances in the sexual health field in a clear and readable form and by providing reviews which highlight the most important papers recently published from the wealth of original publications. We accomplish this by appointing authorities in the following subject areas to select topics to be reviewed by leading experts in the field. · Male Sexual Dysfunction· Female Sexual Dysfunction· Current Controversies (in Sexual Health/Medicine)· Sex Addiction and Compulsion· Surgical Interventions· Preclinical Trials and Psychophysiology· Medical Comorbidities · Mental Health Aspects of Sex Additionally, an international Editorial Board ensures that the journal content includes current, emerging research and suggests articles of special interest to their country or region.
The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.